These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18419506)
1. Antiretroviral drug resistance among antiretroviral-naive individuals with HIV infection of unknown duration in Thailand. Apisarnthanarak A; Mundy LM Clin Infect Dis; 2008 May; 46(10):1630-1. PubMed ID: 18419506 [No Abstract] [Full Text] [Related]
2. Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects. Vicenti I; Razzolini F; Saladini F; Romano L; Zazzi M Clin Infect Dis; 2007 Jun; 44(12):1657-61. PubMed ID: 17516412 [TBL] [Abstract][Full Text] [Related]
3. Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand. Apisarnthanarak A; Jirayasethpong T; Sa-nguansilp C; Thongprapai H; Kittihanukul C; Kamudamas A; Tungsathapornpong A; Mundy LM HIV Med; 2008 May; 9(5):322-5. PubMed ID: 18400079 [TBL] [Abstract][Full Text] [Related]
4. HIV drug resistance transmission threshold survey in Bangkok, Thailand. Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199 [TBL] [Abstract][Full Text] [Related]
5. HIV resistance testing. A clinical tool. Paul SM; Jorden VS N J Med; 2003 Sep; 100(9 Suppl):44-9; quiz 75-6. PubMed ID: 14556603 [TBL] [Abstract][Full Text] [Related]
6. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil. Cardoso LP; Queiroz BB; Stefani MM J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948 [TBL] [Abstract][Full Text] [Related]
7. HIV drug resistance testing. Cane P Methods Mol Biol; 2011; 665():123-32. PubMed ID: 21116799 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection. Smith D; Moini N; Pesano R; Cachay E; Aiem H; Lie Y; Richman D; Little S Clin Infect Dis; 2007 Feb; 44(3):456-8. PubMed ID: 17205459 [TBL] [Abstract][Full Text] [Related]
9. Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations. Ahumada-Ruiz S; Flores-Figueroa D; Toala-González I; Thomson MM Infect Genet Evol; 2009 Sep; 9(5):933-40. PubMed ID: 19559103 [TBL] [Abstract][Full Text] [Related]
10. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2. Ruane PJ; Daar ES AIDS Read; 2004 Sep; 14(9):487-98. PubMed ID: 15457602 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198 [TBL] [Abstract][Full Text] [Related]
12. The global status of resistance to antiretroviral drugs. Vella S; Palmisano L Clin Infect Dis; 2005 Aug; 41 Suppl 4():S239-46. PubMed ID: 16032559 [TBL] [Abstract][Full Text] [Related]
13. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy: a primer for dermatologists. Kim HN; Harrington RD Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782 [TBL] [Abstract][Full Text] [Related]
15. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients]. Cabrera C; Clotet B Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779 [No Abstract] [Full Text] [Related]
16. HIV in 2010: potent antiretroviral drugs treat and sensitive assays monitor the infection; but there remain outstanding issues. Antonelli G Clin Microbiol Infect; 2010 Oct; 16(10):1509-10. PubMed ID: 20854461 [No Abstract] [Full Text] [Related]
17. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200 [TBL] [Abstract][Full Text] [Related]
18. HIV clinical trial design for antiretroviral development: moving forward. Chan-Tack KM; Struble KA; Morgensztejn N; Murray JS; Gulick R; Cheng B; Weller I; Miller V AIDS; 2008 Nov; 22(18):2419-27. PubMed ID: 19005265 [No Abstract] [Full Text] [Related]
19. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592 [TBL] [Abstract][Full Text] [Related]
20. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia. Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]